abstract |
The present invention relates to dihydropyrazole compounds useful for the treatment of cell proliferative diseases, the treatment of disorders associated with KSP kinesin activity, and inhibition of KSP kinesin. The invention also relates to compositions comprising these compounds and methods of using them for the treatment of cancer in mammals. |